229 related articles for article (PubMed ID: 29156346)
1. ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143.
Abdel Gaber SA; Müller P; Zimmermann W; Hüttenberger D; Wittig R; Abdel Kader MH; Stepp H
J Photochem Photobiol B; 2018 Jan; 178():182-191. PubMed ID: 29156346
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
3. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells.
Horibe S; Nagai J; Yumoto R; Tawa R; Takano M
J Pharm Sci; 2011 Jul; 100(7):3010-7. PubMed ID: 21274848
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity of glioma cells to pyropheophorbide-αmethyl ester-mediated photodynamic therapy is enhanced by inhibiting ABCG2.
Pan L; Lin H; Tian S; Bai D; Kong Y; Yu L
Lasers Surg Med; 2017 Sep; 49(7):719-726. PubMed ID: 28370217
[TBL] [Abstract][Full Text] [Related]
5. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
Selbo PK; Weyergang A; Eng MS; Bostad M; Mælandsmo GM; Høgset A; Berg K
J Control Release; 2012 Apr; 159(2):197-203. PubMed ID: 22349185
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
7. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Robey RW; Steadman K; Polgar O; Bates SE
Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
[TBL] [Abstract][Full Text] [Related]
9. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
Sabnis NG; Miller A; Titus MA; Huss WJ
Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
Barron GA; Moseley H; Woods JA
J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Therapy Using Photosensitizer-Encapsulated Polymeric Nanoparticle to Overcome ATP-Binding Cassette Transporter Subfamily G2 Function in Pancreatic Cancer.
Roh YJ; Kim JH; Kim IW; Na K; Park JM; Choi MG
Mol Cancer Ther; 2017 Aug; 16(8):1487-1496. PubMed ID: 28416605
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer.
Hui YJ; Chen H; Peng XC; Li LG; Di MJ; Liu H; Hu XH; Yang Y; Zhao KL; Li TF; Yu TT; Wang WX
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103558. PubMed ID: 37030434
[TBL] [Abstract][Full Text] [Related]
13. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
14. Chlorin e6 combined with albumin nanoparticles as a potential composite photosensitizer for photodynamic therapy of tumors.
Shton IO; Sarnatskaya VV; Prokopenko IV; Gamaleia NF
Exp Oncol; 2015 Dec; 37(4):250-4. PubMed ID: 26710836
[TBL] [Abstract][Full Text] [Related]
15. Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.
Nishie H; Kataoka H; Yano S; Yamaguchi H; Nomoto A; Tanaka M; Kato A; Shimura T; Mizoshita T; Kubota E; Tanida S; Joh T
Biochem Biophys Res Commun; 2018 Feb; 496(4):1204-1209. PubMed ID: 29408755
[TBL] [Abstract][Full Text] [Related]
16. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
17. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
[TBL] [Abstract][Full Text] [Related]
19. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.
Kawai N; Hirohashi Y; Ebihara Y; Saito T; Murai A; Saito T; Shirosaki T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Shichinohe T; Li L; Hirano S; Torigoe T
PLoS One; 2019; 14(5):e0216503. PubMed ID: 31083682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
